Drug intelligence / Profile preview

immune globulin (human)

Development stage
Approved
Lead developer
Grifols
Modality
Antibody-Based Therapeutics
Administration
Intramuscular
01

Overview

GamaSTAN is a brand name for immune globulin (human), a sterile solution of concentrated antibodies (primarily IgG) derived from pooled human plasma. Developed and marketed by Grifols Therapeutics, it is administered via intramuscular injection to provide immediate, passive immunity. It is primarily indicated for post-exposure prophylaxis of hepatitis A and to prevent or modify the clinical course of measles, rubella, and varicella in susceptible individuals. The product contains 15–18% protein and is stabilized with glycine. Unlike intravenous immune globulin (IVIG) products, GamaSTAN is designed strictly for intramuscular use, with peak IgG levels typically reached approximately 2 days after administration.

Brand names
GamaSTANGamaSTAN S/D
Other names
IGIMImmune Globulin IntramuscularHuman Normal Immunoglobulin

Beyond the preview

Go deeper on immune globulin (human).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on immune globulin (human).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call